CHI3L1 and central nervous system cancer: Steponaitis et al. conducted a study revealing elevated mRNA levels of CHI3L1 in glioma tissues compared to adjacent tissues, and this increased CHI3L1 expression was found to be associated with poor prognosis in patients with glioma [38].